Ubs Asset Management Americas Inc Ligand Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 391,789 shares of LGND stock, worth $59.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
391,789
Previous 55,327
608.13%
Holding current value
$59.8 Million
Previous $5.82 Million
665.65%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding LGND
# of Institutions
293Shares Held
19.4MCall Options Held
9KPut Options Held
3.5K-
Black Rock Inc. New York, NY2.87MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$319 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$162 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$141 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$114 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.58B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...